Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-05 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.0001 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |